Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

by Li Shen Loo, Jessica Ailani, Jack Schim, Simin Baygani, Hans-Peter Hundemer, Martha Port, John H. Krege
Published 2019-07-01

Long-term safety and efficacy of lasmiditan for acute treatment of migraine: Final results of the GLADIATOR study

by Jan Lewis Brandes, Suzanne Klise, John H Krege, Michael Case, Rashna Khanna, Raghavendra Vasudeva, Joel Raskin, David Kudrow
Published 2020-09-01

Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)

by Li Shen Loo, Brian M. Plato, Ira M. Turner, Michael G. Case, Joel Raskin, Sherie A. Dowsett, John H. Krege
Published 2019-08-01

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

by Timothy Smith, John H. Krege, Suchitrita S. Rathmann, Sherie A. Dowsett, Ann Hake, Emel S. M. Nery, Brandy R. Matthews, Erin G. Doty
Published 2020-05-01

Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study

by Richard B. Lipton, Louise Lombard, Dustin D. Ruff, John H. Krege, Li Shen Loo, Andrew Buchanan, Thomas E. Melby, Dawn C. Buse
Published 2020-02-01

A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SP...

by Richard B. Lipton, Simin K. Baygani, Stewart J. Tepper, John H. Krege, Raghavendra Vasudeva, Eric M. Pearlman, Paula M. Hauck, Li Shen Loo
Published 2021-08-01